Clinical Trial Update: Phase III Study of Tolvaptan Tablet to Treat Cirrhosis Ascites [Phase 3]

View source ↗

Summary

A Phase III clinical trial evaluating tolvaptan tablets for treating ascites due to hepatic cirrhosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ascites
• Hepatic Cirrhosis

Drugs mentioned

• tolvaptan (tolvaptan)

Snippet

Sponsor: Otsuka Beijing Research Institute | Conditions: Ascites, Hepatic Cirrhosis | Phase 3 | Status: COMPLETED